Marty McGuinn, a longtime Eye & Ear Foundation donor and Pittsburgh dignitary, passed away in May. The former Chairman and CEO of Mellon Financial Corporation leaves a lasting impact on […]
Marty McGuinn, a longtime Eye & Ear Foundation donor and Pittsburgh dignitary, passed away in May. The former Chairman and CEO of Mellon Financial Corporation leaves a lasting impact on […]
The Systems Pharmacology Lab of Retinal Degenerationof Yuanyuan, run by Yuanyuan Chen, PhD, focuses on pharmacological studies of inherited retinal disease and age-related retinal degeneration. The lab develops drug screening […]
Read More… from Developing New Drug Candidates for Retinal Diseases
At the start of the Eye & Ear Foundation’s August 6 webinar, “Inherited Retinal Conditions: Current Treatments and Future Research,” Dr. José-Alain Sahel, MD, Distinguished Professor and Chairman of the […]
Read More… from Inherited Retinal Conditions: Current Treatments and Future Research
Many advancements have occurred in the field of gene therapy since the last webinar on this topic. The Eye & Ear Foundation’s June 25th webinar, “Seeing the Future of Gene […]
Yuanyuan Chen, PhD, has a lab that is developing drugs for retinal diseases. Morgan V. DiLeo, PhD, has a lab that is developing new delivery methods for these drugs. Both […]
The Department of Ophthalmology at the University of Pittsburgh School of Medicine was the first in the world to use optogenetics to restore vision. The Eye & Ear Foundation’s August […]
A lot of progress has been made in the past few years on retinal degeneration, Dr. José-Alain Sahel said at the beginning of the Eye & Ear Foundation’s May 18th […]
Read More… from Retinal Dystrophies: Introduction, Therapies and Ongoing Research
Sight + Sound, Fall 2021 After 40 years of total blindness, a 58-year-old French man saw stripes in a crosswalk. He was also able to reach out and touch a […]